101140.KS
INBIOGEN Co., Ltd.
KSC · Consumer Cyclical · Apparel - Footwear & Accessories · KR
KRW 5,510.00
−1.61%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.1B | 6.3B | 7.0B | 6.2B | 11.4B |
| Cost of Revenue | 5.7B | 6.9B | 6.4B | 5.0B | 8.8B |
| Gross Profit | (546.6M) | (574.4M) | 660.1M | 1.3B | 2.6B |
| Operating Expenses | |||||
| R&D Expense | — | — | 21.9M | 8.2M | 3.7M |
| SG&A Expense | 1.8B | 1.8B | 2.6B | 2.9B | 4.2B |
| General & Admin Expense | 145.5M | 224.1M | 339.3M | 1.3B | 1.9B |
| Selling & Marketing Expense | 889.6M | 1.5B | 2.2B | 1.6B | 2.3B |
| Other Expenses | 1.6B | 2.0B | 4.2B | 4.6B | 4.3B |
| Total Operating Expenses | 3.4B | 3.8B | 6.8B | 7.5B | 8.5B |
| Cost and Expenses | 9.0B | 10.6B | 13.1B | 12.4B | 17.3B |
| Operating Income (EBIT) | (3.9B) | (4.3B) | (6.1B) | (6.2B) | 44.0B |
| Non-Operating | |||||
| Interest Income | 929.5M | 864.4M | 924.9M | 1.3B | 1.8B |
| Interest Expense | 141.0M | 78.5M | 51.4M | 262.1M | 3.7B |
| Net Interest Income | 788.5M | 785.9M | 873.6M | 1.0B | 7.9B |
| Other Non-Op Income/Expense | (16.8B) | 2.9B | 22.2B | 25.5B | (130.6B) |
| Non-Operating Income (excl Interest) | 2.5B | — | (22.3B) | (18.3B) | 126.9B |
| EBT (Pre-Tax Income) | (20.7B) | (1.4B) | 16.1B | 19.4B | (136.6B) |
| Income Tax Expense | — | — | — | — | (17.0B) |
| Bottom Line | |||||
| Net Income | (20.7B) | 5.8B | 16.1B | 18.9B | (119.7B) |
| Earnings from Cont. Ops | (20.7B) | 5.8B | 16.1B | 19.4B | (119.4B) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (20.7B) | 5.8B | 16.1B | 18.9B | (119.7B) |
| Per Share | |||||
| Basic EPS | (₩4,162) | ₩580 | ₩1,615 | ₩1,887 | (₩33,008) |
| Diluted EPS | (₩4,162) | ₩580 | ₩1,615 | ₩1,887 | (₩33,008) |
| Revenue Per Share | ₩10,223 | ₩627 | ₩705 | ₩625 | ₩3,145 |
| Shares | |||||
| Basic Shares Outstanding | 499238 | 10.0M | 10.0M | 10.0M | 3.6M |
| Diluted Shares Outstanding | 499238 | 10.0M | 10.0M | 10.0M | 3.6M |
| Profitability Metrics | |||||
| EBITDA | 5.5B | (4.0B) | 17.2B | 13.3B | 45.5B |
| D&A | 136.6M | 363.5M | 1.1B | 1.2B | 1.4B |
| EBIT | 5.3B | (4.3B) | 16.2B | 12.1B | (132.7B) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026